Cleared Traditional

K883911 - ELECTRO-ACUSCOPE 85

K883911 is the FDA 510(k) clearance for ELECTRO-ACUSCOPE 85 by Biomedical Design Instruments. It is a Class 2 Neurology device (product code GZJ) cleared through the Traditional 510(k) pathway after a 505-day FDA review.

K883911 · Biomedical Design Instruments · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1990
Decision
505d
Days
Class 2
Risk

K883911 is an FDA 510(k) clearance for the ELECTRO-ACUSCOPE 85. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Biomedical Design Instruments (Los Angeles, US). The FDA issued a Cleared decision on February 2, 1990 after a review of 505 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Biomedical Design Instruments devices

Submission Details

510(k) Number K883911 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 15, 1988
Decision Date February 02, 1990
Days to Decision 505 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
357d slower than avg
Panel avg: 148d · This submission: 505d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 138
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K883911.
MC II (TM), MODEL 7200S
K903161 · Medical Devices, Inc. · Mar 1991
SYNAPS (TM)
K903828 · Henley Intl. · Jan 1991
NEUROTENS
K896620 · Henley Intl. · Apr 1990
DSX(TM), DIGITAL SX, QUANTUM DSX, MODEL 4700S
K895473 · Medical Devices, Inc. · Dec 1989
TTS2800
K895161 · Henley Intl. · Oct 1989
TTS2500
K895166 · Henley Intl. · Oct 1989